Proteome Sciences PLC (GB:PRM)
LSE:PRM
Want to see GB:PRM full AI Analyst Report?
Total Valuation
Proteome Sciences has a market cap or net worth of £5.23M. The enterprise value is 19.08M .
Market Cap£5.23M
Enterprise Value19.08M
Share Statistics
Proteome Sciences has 350,724,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding350,724,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteome Sciences’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is -34.27%.
Return on Equity (ROE)0.32
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-34.27%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee104.33K
Profits Per Employee-85.03K
Employee Count36
Asset Turnover0.45
Inventory Turnover8.87
Valuation Ratios
The current PE Ratio of Proteome Sciences is ―. Proteome Sciences’s PEG ratio is 0.25.
PE Ratio―
PS Ratio1.96
PB Ratio-0.77
Price to Fair Value-0.77
Price to FCF-51.61
Price to Operating Cash Flow-90.80
PEG Ratio0.25
Income Statement
In the last 12 months, Proteome Sciences had revenue of 3.76M and earned -3.06M in profits. Earnings per share was -0.01.
Revenue3.76M
Gross Profit-1.01M
Operating Income-2.67M
Pretax Income-3.59M
Net Income-3.06M
EBITDA-1.74M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -46.00K and capital expenditures -97.00K, giving a free cash flow of -143.00K billion.
Operating Cash Flow-46.00K
Free Cash Flow-143.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Proteome Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change-49.64%
50-Day Moving Average1.71
200-Day Moving Average2.33
Relative Strength Index (RSI)19.34
Average Volume (3m)476.64K
Important Dates
Proteome Sciences upcoming earnings date is Aug 26, 2026, TBA (Confirmed).
Last Earnings DateApr 15, 2026
Next Earnings DateAug 26, 2026
Ex-Dividend Date―
Financial Position
Proteome Sciences as a current ratio of 0.13, with Debt / Equity ratio of -165.46%
Current Ratio0.13
Quick Ratio0.09
Debt to Market Cap2.03
Net Debt to EBITDA-8.61
Interest Coverage Ratio-2.88
Taxes
In the past 12 months, Proteome Sciences has paid -530.00K in taxes.
Income Tax-530.00K
Effective Tax Rate0.15
Enterprise Valuation
Proteome Sciences EV to EBITDA ratio is -12.86, with an EV/FCF ratio of -156.42.
EV to Sales5.96
EV to EBITDA-12.86
EV to Free Cash Flow-156.42
EV to Operating Cash Flow-486.27
Balance Sheet
Proteome Sciences has £781.00K in cash and marketable securities with £15.77M in debt, giving a net cash position of -£14.99M billion.
Cash & Marketable Securities£781.00K
Total Debt£15.77M
Net Cash-£14.99M
Net Cash Per Share-£0.04
Tangible Book Value Per Share-£0.05
Margins
Gross margin is -26.81%, with operating margin of -70.98%, and net profit margin of -81.50%.
Gross Margin-26.81%
Operating Margin-70.98%
Pretax Margin-95.61%
Net Profit Margin-81.50%
EBITDA Margin-46.33%
EBIT Margin-70.98%
Analyst Forecast
The average price target for Proteome Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-23.14%
EPS Growth Forecast9.57%